Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Tangible Net Worth Ratio
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Tangible Net Worth Ratio of 36.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥273.08 Million) from net assets (CN¥429.55 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Hainan Huluwa Pharmaceutical Group Co Lt net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hainan Huluwa Pharmaceutical Group Co Ltd Tangible Net Worth Ratio (2016–2025)
This chart shows how Hainan Huluwa Pharmaceutical Group Co Ltd's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 36.4%, reflecting net assets of CN¥429.55 Million with intangible assets of CN¥273.08 Million CNY. Also explore 605199 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 605199 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 40.1% | CN¥458.02 Million | CN¥274.49 Million | CN¥2.60 Billion | ▼ -23.2 pp |
| 2024 | 63.3% | CN¥743.28 Million | CN¥272.95 Million | CN¥2.96 Billion | ▼ -14.7 pp |
| 2023 | 78.0% | CN¥1.16 Billion | CN¥255.46 Million | CN¥3.06 Billion | ▼ -6.6 pp |
| 2022 | 84.6% | CN¥1.02 Billion | CN¥156.66 Million | CN¥2.31 Billion | ▼ -0.9 pp |
| 2021 | 85.4% | CN¥930.52 Million | CN¥135.62 Million | CN¥1.76 Billion | ▼ -0.5 pp |
| 2020 | 85.9% | CN¥916.48 Million | CN¥128.95 Million | CN¥1.52 Billion | ▼ -1.2 pp |
| 2019 | 87.2% | CN¥643.94 Million | CN¥82.68 Million | CN¥1.09 Billion | ▲ +2.4 pp |
| 2018 | 84.8% | CN¥604.61 Million | CN¥92.12 Million | CN¥1.09 Billion | ▲ +14.0 pp |
| 2017 | 70.8% | CN¥351.38 Million | CN¥102.59 Million | CN¥807.21 Million | ▲ +56.6 pp |
| 2016 | 14.3% | CN¥128.69 Million | CN¥110.35 Million | CN¥535.95 Million | — |